Target intelligence / Profile preview

Beclin-1 (Beclin1)

Target
Beclin1
Molecular classification
Other (autophagy regulatory protein), Signaling molecule, Scaffolding protein
01

Overview

Beclin-1 is a scaffolding protein crucial for initiating autophagy in mammalian cells, encoded by the BECN1 gene in humans[1][5]. It is the mammalian ortholog of yeast Atg6, and interacts with class III phosphoinositide 3-kinase (PI3K) complexes and Bcl-2 family proteins to regulate both autophagy and apoptosis[1][3][5]. Structurally, Beclin-1 contains an N-terminal intrinsically disordered region (with a Bcl-2 homology 3/BH3 domain), a central coiled-coil domain that mediates protein interactions, and a C-terminal evolutionarily conserved (BARA/ECD) domain with membrane-binding properties crucial for autophagic function[1][2][3]. Beclin-1 serves as a hub for membrane trafficking and signal integration, orchestrating the formation and maturation of autophagosomes by recruiting and regulating key autophagy proteins such as VPS34, VPS15, UVRAG, and ATG14[1][3]. It is implicated in multiple disease processes—including cancer (as a haploinsufficient tumor suppressor), neurodegenerative disorders, and inflammation—largely due to its central role in maintaining cellular homeostasis by promoting proper turnover of cellular components and regulating cell death[3][5]. Loss or mutation of Beclin-1 is associated with increased tumor development, impaired autophagy, and defective cellular clearance pathways[5].

Other names
Beclin1BECN1Autophagy-related protein 6 (ATG6)Beclin-1Beclin 1
02

Mechanism of action

Induction of autophagy via increased Beclin-1 expression or activity, Modulation of protein-protein interactions in the autophagy machinery

03

Biological functions

Autophagy regulationMembrane traffickingApoptosis regulationTumor suppressionSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseInflammationInfectionOther
05

Safety considerations

Potential for disturbance of cellular homeostasis with over- or under-activation (autophagic cell death, defective clearance)Oncogenic risk with loss of functionNeurotoxicity upon dysregulated autophagy
06

Interacting drugs

Trehalose (stimulates Beclin-1-mediated autophagy in animal models)[5]
07

Biomarkers

Decreased Beclin-1 levels as a biomarker for impaired autophagy (in cancer, neurodegeneration)[5]

Beyond the preview

Go deeper on Beclin-1 (Beclin1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beclin-1 (Beclin1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call